Literature DB >> 25336557

5-Fluorouracil-induced bilateral persistent serpentine supravenous hyperpigmented eruption, bilateral mottling of palms and diffuse hyperpigmentation of soles.

Swastika Suvirya1, Avinash Agrawal2, Anit Parihar3.   

Abstract

A 42-year-old woman being treated with 5-fluorouracil for carcinoma of the sigmoid colon developed persistent serpentine supravenous hyperpigmented eruption (PSSHE), bilateral mottling of the palms and diffuse hyperpigmentation of the soles. To the best of our knowledge, such a combination of findings has not been reported earlier. Recognition and knowledge of this side effect are important as the dose of the drug need not be altered nor is there a need to replace the drug on worries about a serious adverse effect. However, changing the peripheral venous route to the central line can be useful in management of PSSHE. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25336557      PMCID: PMC4208118          DOI: 10.1136/bcr-2014-206793

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Unusual serpentine hyperpigmentation associated with 5-fluorouracil. Case report and review of cutaneous manifestations associated with systemic 5-fluorouracil.

Authors:  S J Vukelja; M W Bonner; M McCollough; P W Cobb; D A Gaule; P J Fanucchi; J H Keeling
Journal:  J Am Acad Dermatol       Date:  1991-11       Impact factor: 11.527

2.  Localized epidermal necrolysis (erythema multiforme-like reaction) following intravenous injection of vinblastine.

Authors:  D Arias; L Requena; A Hasson; M Gutierrez; M Domine; L Martin; A Barat
Journal:  J Cutan Pathol       Date:  1991-10       Impact factor: 1.587

3.  Chemotherapy-associated supravenous hyperpigmentation.

Authors:  E Baselga; B A Drolet; J Casper; N B Esterly
Journal:  Dermatology       Date:  1996       Impact factor: 5.366

4.  Letter: Serpentine supravenous fluorouracil hyperpigmentation.

Authors:  W J Hrushesky
Journal:  JAMA       Date:  1976-07-12       Impact factor: 56.272

5.  Letter: Hyperpigmentation after cancer chemotherapy.

Authors:  C S O'Doherty
Journal:  Lancet       Date:  1975-08-23       Impact factor: 79.321

6.  Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bromodeoxyuridine) therapy and radiotherapy.

Authors:  J D Fine; S M Breathnach
Journal:  Arch Dermatol       Date:  1986-02

7.  Persistent serpentine supravenous hyperpigmented eruption associated with docetaxel.

Authors:  I Aydogan; A Kavak; A H Parlak; M Alper; A N Annakkaya; M Erbas
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-05       Impact factor: 6.166

Review 8.  5-fluorouracil: mechanisms of action and clinical strategies.

Authors:  Daniel B Longley; D Paul Harkin; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

Review 9.  Persistent supravenous erythematous eruption: a rare local complication of intravenous 5-fluorouracil therapy.

Authors:  R M Pujol; V Rocamora; A Lopez-Pousa; R Taberner; A Alomar
Journal:  J Am Acad Dermatol       Date:  1998-11       Impact factor: 11.527

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.